ATE90690T1 - Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung. - Google Patents

Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung.

Info

Publication number
ATE90690T1
ATE90690T1 AT88904042T AT88904042T ATE90690T1 AT E90690 T1 ATE90690 T1 AT E90690T1 AT 88904042 T AT88904042 T AT 88904042T AT 88904042 T AT88904042 T AT 88904042T AT E90690 T1 ATE90690 T1 AT E90690T1
Authority
AT
Austria
Prior art keywords
carrier protein
protein subunits
production
methods
human
Prior art date
Application number
AT88904042T
Other languages
English (en)
Inventor
Emerald Martin Spencer
Original Assignee
Celtrix Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celtrix Pharma filed Critical Celtrix Pharma
Application granted granted Critical
Publication of ATE90690T1 publication Critical patent/ATE90690T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT88904042T 1987-04-06 1988-03-31 Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung. ATE90690T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3488587A 1987-04-06 1987-04-06
PCT/US1988/001042 WO1988007863A1 (en) 1987-04-06 1988-03-31 Human somatomedin carrier protein subunits and process for producing them
EP88904042A EP0308500B1 (de) 1987-04-06 1988-03-31 Menschliche somatomedin-träger-protein-untereinheiten und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ATE90690T1 true ATE90690T1 (de) 1993-07-15

Family

ID=21879212

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88904042T ATE90690T1 (de) 1987-04-06 1988-03-31 Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung.

Country Status (11)

Country Link
EP (2) EP0308500B1 (de)
JP (1) JP2648951B2 (de)
AT (1) ATE90690T1 (de)
AU (1) AU627423B2 (de)
CA (1) CA1340295C (de)
DE (1) DE3881801T2 (de)
DK (1) DK677688D0 (de)
ES (1) ES2058341T3 (de)
IL (1) IL85983A (de)
WO (1) WO1988007863A1 (de)
ZA (1) ZA882407B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973115A (en) * 1987-05-15 1999-10-26 Amgen Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
ATE132164T1 (de) * 1988-04-12 1996-01-15 Amgen Boulder Inc Verfahren zur steigerung und zur hemmung der wirkung eines insulinähnlichen wachstumfaktors
US6465423B1 (en) 1988-07-15 2002-10-15 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
JP3178714B2 (ja) * 1988-07-15 2001-06-25 セントラル・シドニー・エリア・ヘルス・サービス インスリン様成長因子（ｉｇｆ）結合蛋白複合体の酸不安定サブユニット（ａｌｓ）
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
CA2195474A1 (en) * 1994-07-20 1996-02-01 Cedo Martin Bagi Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
ES2329220T3 (es) 1999-01-06 2009-11-24 Genentech, Inc. Variantes mutantes del factor de crecimiento similar a insulina (igf) i.
EP1141014B1 (de) 1999-01-06 2004-12-08 Genentech, Inc. Mutierte variante des insulin-ähnlichen wachstumsfaktor-i (igf-i)
EP1282437B1 (de) 2000-05-16 2008-03-19 Genentech, Inc. Behandlung von knorpelerkrankungen
JP4117731B2 (ja) 2001-03-14 2008-07-16 ジェネンテック・インコーポレーテッド Ｉｇｆアンタゴニストペプチド
WO2005016970A2 (en) 2003-05-01 2005-02-24 Imclone Systems Incorporated Fully human antibodies directed against the human insulin-like growth factor-1 receptor
NZ545940A (en) 2003-09-12 2009-12-24 Tercica Inc Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency
US7192738B2 (en) 2003-10-03 2007-03-20 Genentech, Inc. IGF binding proteins
CN101613409B (zh) 2005-06-17 2014-06-04 英克隆有限责任公司 抗-PDGFRα抗体
CA2641310C (en) 2006-02-03 2013-08-20 Imclone Systems Incorporated Igf-ir antagonists as adjuvants for treatment of prostate cancer
EP3681602A1 (de) 2017-09-11 2020-07-22 Shire Human Genetic Therapies, Inc. Verfahren und zusammensetzungen zur behandlung chronischer lungenerkrankungen
TW202233228A (zh) 2020-10-19 2022-09-01 美商舒爾人類基因療法公司 適用於新生兒的組成物
WO2023139115A1 (en) 2022-01-19 2023-07-27 Oak Hill Bio Limited Compositions and methods for reducing oxidation of igf‐1/igfbp
WO2023242439A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Vascular stabilisation (preterm infants)
WO2023242440A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Treament of lungs in infants
WO2023242442A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Method of maturing/differentiating neurons and/or modulating the vagus nerve

Also Published As

Publication number Publication date
EP0308500B1 (de) 1993-06-16
ES2058341T3 (es) 1994-11-01
AU1702088A (en) 1988-11-04
AU627423B2 (en) 1992-08-27
IL85983A (en) 1994-10-07
EP0308500A1 (de) 1989-03-29
EP0294021A1 (de) 1988-12-07
CA1340295C (en) 1998-12-29
DE3881801T2 (de) 1993-12-23
JP2648951B2 (ja) 1997-09-03
ZA882407B (en) 1988-09-28
DK677688A (da) 1988-12-05
IL85983A0 (en) 1988-09-30
WO1988007863A1 (en) 1988-10-20
DK677688D0 (da) 1988-12-05
DE3881801D1 (de) 1993-07-22
JPH01502986A (ja) 1989-10-12

Similar Documents

Publication Publication Date Title
ATE90690T1 (de) Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung.
ZA899832B (en) Human somatomedin carrier protein subunits and process for producing them;recombinant dna molecules,hosts,processes and human somatomedian carrier protein-like polypeptides
DK564989A (da) Bindingsproteiner
DE3783191D1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
FI97299C (fi) Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi
FI101542B1 (fi) Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi
AU576508B2 (en) Sythetic peptides antigenically corresponding to brain specific proteinoids
ATE127478T1 (de) Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung.
HUT55800A (en) Process for producing anticoagulant peptides
DE68917379D1 (de) Verfahren zur Herstellung von Proteinen, die ähnlich dem natürlich-menschlichen Apolipoprotein-E sind.
ATE81013T1 (de) Verfahren zur herstellung von faktor viii:cmangelplasma und ein so erhaltenes mangelplasma.
ATE73125T1 (de) Verfahren zur herstellung von dialkylaminoethylaminen.